NASDAQ:CSTL

Castle Biosciences Stock Predictions

Healthcare > Medical - Diagnostics & Research

Buy CSTL

*Your capital is at risk

$20.39

+0.680 (+3.45%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CSTL Prediction Chart

CSTL Predictions History

Latest community submissions for CSTL.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
dbuta12	Sep 30, 2025	$22.36 +0.00%	$22.77	X	98.20%
JS Pro	Jun 29, 2021	$78.67 +5.31%	$74.70	X	94.69%
lpjz50	Jun 29, 2021	$82.00 +9.77%	$74.70	X	90.23%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CSTL with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CASTLE BIOSCIENCES, INC.

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients w...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by